中国全科医学2024,Vol.27Issue(21) :2665-2671.DOI:10.12114/j.issn.1007-9572.2023.0069

肠道菌群在脓毒症相关性肝损伤发病与治疗中的作用研究进展

Research Progress on the Role of Gut Microbiota in the Pathogenesis and Treatment of Sepsis-associated Liver Injury

陈文胜 刘文明
中国全科医学2024,Vol.27Issue(21) :2665-2671.DOI:10.12114/j.issn.1007-9572.2023.0069

肠道菌群在脓毒症相关性肝损伤发病与治疗中的作用研究进展

Research Progress on the Role of Gut Microbiota in the Pathogenesis and Treatment of Sepsis-associated Liver Injury

陈文胜 1刘文明1
扫码查看

作者信息

  • 1. 213000 江苏省常州市,南京医科大学附属常州第二人民医院重症医学科
  • 折叠

摘要

脓毒症的特点是对感染的免疫反应失调,导致威胁生命的器官功能障碍.脓毒症相关性肝损伤(SALI)被认为是重症监护室(ICU)中预测患者死亡的独立危险因素.随着近年来对肠-肝轴的研究越来越多,肠道菌群与肝脏疾病的密切联系逐步被揭开.肠道菌群失调被证明可以通过丝裂原活化蛋白激酶/核转录因子κB(MAPK/NF-κB)信号通路和损害肠道屏障诱发SALI.同时,粪便微生物移植(FMT)和益生菌的使用在SALI的治疗中具有很大的潜力.本文综述了近年来国内外相关研究进展,以期为SALI的发病和治疗提供新的见解.

Abstract

Sepsis is characterized by a dysregulation of immune response to infection,leading to life-threatening organ dysfunction.Sepsis-associated liver injury(SALI)is considered an independent risk factor for predicting death in the intensive care unit(ICU).With the increasing number of studies on the gut-liver axis in recent years,the close linkage of gut microbiota and liver diseases has been gradually revealed.Dysbiosis of gut microbiota has been shown to induce SALI through the mitogen-activated protein kinase/nuclear transcription factor κB(MAPK/NF-κB)signaling pathway and damage to the intestinal barrier.Meanwhile,fecal microbiota transplantation(FMT)and the application of probiotics have great potential in the treatment of SALI.This paper reviews the relevant research progress in recent years both at home and abroad,in order to provide new insights into the pathogenesis and treatment of SALI.

关键词

胃肠道微生物组/肠道菌群/脓毒症/肝损伤/粪便微生物移植/益生菌/综述

Key words

Gastrointestinal microbiome/Gut microbiota/Sepsis/Liver injury/FMT/Probiotics/Review

引用本文复制引用

基金项目

吴阶平医学基金会临床科研专项(320.6750.2022-02-20)

出版年

2024
中国全科医学
中国医院协会

中国全科医学

CSTPCD北大核心
影响因子:2.04
ISSN:1007-9572
参考文献量61
段落导航相关论文